*Correspondence: Gunda Herberth, [email protected] These authors share first authorship These authors share senior authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Impact of GLP-1 Analogs on Gut Microbiota: Preclinical and Clinical Insights GLP-1RAs, such as liraglutide, semaglutide, and dulaglutide, are increasingly acknowledged for their potential to affect gut microbiota in addition to their well-known functions in regulating blood glucose levels and aiding in weight loss [1-4]
GLP-1 agonists may be preferable in some elderly patients due to lower hypoglycemia risk, though GI side effects and potential for weight loss (which can be undesirable in frail elderly patients) require careful consideration
The Relationship Between Glutathione and Sleep The question of whether glutathione makes you sleepy is usually a matter of terminology
Non-Diabetes Specialists Drive New Growth in GLP-1 Prescriptions Patients with Type 2 diabetes (T2D) and obesity often present with multiple comorbidities spanning a wide range of diseases, requiring care from diverse specialists